merged_drug-prices-medicare.txt
<question_number>1</question_number>
<answer>the $2,000 annual cap goes into effect next year; new prices in 2026</answer>
<question_number>2</question_number>
<answer>the number of drugs negotiated is set to increase; Project 2025 suggests repeal</answer>
<question_number>3</question_number>
<answer>she cast the tiebreaking vote for the legislation; focuses on drug pricing reforms</answer>
<question_number>4</question_number>
<answer>Enbrel</answer>
<question_number>5</question_number>
<answer>approximately $730</answer>
<question_number>6</question_number>
<answer>Enbrel</answer>
<question_number>7</question_number>
<answer>Enbrel</answer>
<question_number>8</question_number>
<answer>approximately 73.5%</answer>
<question_number>9</question_number>
<answer>$19</answer>
<question_number>10</question_number>
<answer>$6,000</answer>